Skip to content

SJM™ SARP-26Recalls & reported problems

St. Jude Medical, Inc. · For Mitral Valve Repair · Class 2 · Implant

All models of SJM (31)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05414734007498), received between Sep 8, 2021 and Nov 21, 2023 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Lack of Effect” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Lack of Effect1

Patient problems

  • Coagulation Disorder1
  • Mitral Valve Insufficiency/ Regurgitation1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 21, 2023Lack of Effect; Lack of Effect

    IT WAS REPORTED THAT ON 23 OCTOBER 2023, A 26MM SEGUIN ANNULOPLASTY RING WAS SELECTED FOR AN IMPLANT. DURING SALINE TEST THE PHYSICIAN FOUND THE REPAIR WAS NOT ADEQUATE AS THERE WAS SEVERE MITRAL REGURGITATION GRADE-4. HE EXPLANTED THE RING AND REPLACED WITH A NON-ABBOTT MITRAL VALVE. THE PATIENT IS STABLE.

    Patient problems: Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 18184083 ↗
  • InjurySep 8, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    SUBSEQUENT TO THE INITIALLY FILED INFORMATION, THE FOLLOWING INFORMATION WAS RECEIVED ON (B)(6) 2021: IT WAS REPORTED THAT THE AFIBRINOGENEMIA DIAGNOSIS IN THIS EVENT WAS USED TO DOCUMENT TEMPORARY CHANGES IN FIBRINOGEN LEVELS IN THE BLOOD. THEREFORE THE INFORMATION REPORTED INITIALLY REMAINS A REPORTABLE EVENT.

    Patient problems: Coagulation Disorder

    MAUDE report 12438938 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page